BRCA2 and Familial prostate cancer: In a study of 6500 patients with BRCA1 and BRCA2 PVs, c.756-c 1000 and c.7914þ regions in BRCA2 were reported as negative biomarkers for high risk of Gleason 8b prostate cancer [85].